- Home
- SLI vs CYRX Comparison
SLI vs CYRX Comparison
Compare SLI & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SLI
- CYRX
- Stock Information
- Founded
- SLI 1998
- CYRX 1999
- Country
- SLI Canada
- CYRX United States
- Employees
- SLI N/A
- CYRX N/A
- Industry
- SLI Major Chemicals
- CYRX Biotechnology: Pharmaceutical Preparations
- Sector
- SLI Industrials
- CYRX Health Care
- Exchange
- SLI Nasdaq
- CYRX Nasdaq
- Market Cap
- SLI 355.5M
- CYRX 365.5M
- IPO Year
- SLI N/A
- CYRX N/A
- Fundamental
- Price
- SLI $2.24
- CYRX $7.66
- Analyst Decision
- SLI Buy
- CYRX Strong Buy
- Analyst Count
- SLI 1
- CYRX 8
- Target Price
- SLI $4.40
- CYRX $10.75
- AVG Volume (30 Days)
- SLI 1.9M
- CYRX 589.2K
- Earning Date
- SLI 07-15-2025
- CYRX 08-05-2025
- Dividend Yield
- SLI N/A
- CYRX N/A
- EPS Growth
- SLI N/A
- CYRX N/A
- EPS
- SLI N/A
- CYRX N/A
- Revenue
- SLI N/A
- CYRX $232,134,000.00
- Revenue This Year
- SLI $33.34
- CYRX N/A
- Revenue Next Year
- SLI N/A
- CYRX $9.63
- P/E Ratio
- SLI N/A
- CYRX N/A
- Revenue Growth
- SLI N/A
- CYRX 11.75
- 52 Week Low
- SLI $1.07
- CYRX $4.58
- 52 Week High
- SLI $2.64
- CYRX $9.78
- Technical
- Relative Strength Index (RSI)
- SLI 69.26
- CYRX 64.05
- Support Level
- SLI $1.78
- CYRX $6.16
- Resistance Level
- SLI $2.30
- CYRX $7.96
- Average True Range (ATR)
- SLI 0.12
- CYRX 0.44
- MACD
- SLI 0.03
- CYRX 0.06
- Stochastic Oscillator
- SLI 85.00
- CYRX 83.33
About SLI Standard Lithium Ltd.
Standard Lithium Corp is engaged in the exploration and development of lithium brine properties in the United States. The company is focused on the exploration and development of the Arkansas Lithium Project, which is located in south-central Arkansas. Its other projects comprise the Lanxess Project, and Bristol Dry Lake Project.
About CYRX CryoPort Inc.
CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.